首页> 外文期刊>Applied biochemistry and biotechnology, Part A. enzyme engineering and biotechnology >Enhancement of Lovastatin Production by Supplementing Polyketide Antibiotics to the Submerged Culture of Aspergillus terreus
【24h】

Enhancement of Lovastatin Production by Supplementing Polyketide Antibiotics to the Submerged Culture of Aspergillus terreus

机译:通过向土曲霉的水下培养物中补充聚酮类抗生素来增强洛伐他汀的生产

获取原文
获取原文并翻译 | 示例
           

摘要

Feedback inhibition existed in lovastatin biosynthesis from Aspergillus terreus.Exogenous lovastatin and other different polyketide antibiotics biosynthesized by polyketide synthase were supplemented to the cultures of A. terreus to investigate their influences on lovastatin production. Supplementing exogenous lovastatin of 100 mg l1 at the early stage of fermentation and the fast stage of its biosynthesis resulted in decreases of 76.4% and 20% in final lovastatin production, respectively. However, the fungal cell growth was not affected; the growing cycle was only prolonged in the submerged cultivation. Separate supplementation of the five kinds of polyketide antibiotics such as tylosin, erythromycin, tetracycline,daunorobin, and rifamycin to the cultures resulted in increases of about 20~25% in the final lovastatin production. Especially, supplementing tylosin of 50 mg l1 at the beginning of lovastatin biosynthesis led to the final lovastatin production of 952.7±24.3 mg l1, which was improved by 42% and 22% compared with that produced in the control and the original culture, respectively. These results are helpful to understand the regulations on lovastatin biosynthesis and improve the final desired metabolite contents in many antibiotics production.
机译:曲霉曲霉洛伐他汀生物合成中存在反馈抑制作用。在土曲霉中补充外源性洛伐他汀和其他由聚酮化合物合酶生物合成的聚酮化合物抗生素,以研究其对洛伐他汀生产的影响。在发酵的早期和生物合成的快速阶段补充100 mg l1的外源洛伐他汀可以使洛伐他汀的最终产量分别减少76.4%和20%。但是,真菌细胞的生长没有受到影响。深水栽培仅延长了生长周期。分别向培养物中补充泰乐菌素,红霉素,四环素,柔红霉素和利福霉素这五种聚酮类抗生素会导致洛伐他汀的最终产量增加约20%至25%。特别地,在洛伐他汀生物合成开始时补充50 mg l1的泰乐菌素导致洛伐他汀的最终产量为952.7±24.3 mg l1,与对照和原始培养物中的产量相比分别提高了42%和22%。这些结果有助于了解洛伐他汀生物合成的法规,并改善许多抗生素生产中最终所需的代谢产物含量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号